SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/10/22 Alto Ingredients, Inc. 10-Q 3/31/22 58:4.2M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 605K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 10: R1 Document And Entity Information HTML 70K 11: R2 Consolidated Balance Sheets HTML 143K 12: R3 Consolidated Balance Sheets (Parentheticals) HTML 45K 13: R4 Consolidated Statements of Operations (Unaudited) HTML 88K 14: R5 Consolidated Statements of Cash Flows (Unaudited) HTML 108K 15: R6 Consolidated Statements of Stockholders? Equity HTML 61K (Unaudited) 16: R7 Organization and Basis of Presentation HTML 30K 17: R8 Acquisition of Eagle Alcohol HTML 30K 18: R9 Segments HTML 57K 19: R10 Inventories HTML 22K 20: R11 Derivatives HTML 36K 21: R12 Debt HTML 25K 22: R13 Commitments and Contingencies HTML 22K 23: R14 Pension Plans HTML 25K 24: R15 Fair Value Measurements. HTML 71K 25: R16 Earnings Per Share HTML 40K 26: R17 Accounting Policies, by Policy (Policies) HTML 43K 27: R18 Acquisition of Eagle Alcohol (Tables) HTML 28K 28: R19 Segments (Tables) HTML 55K 29: R20 Inventories (Tables) HTML 22K 30: R21 Derivatives (Tables) HTML 35K 31: R22 Debt (Tables) HTML 21K 32: R23 Fair Value Measurements. (Tables) HTML 66K 33: R24 Earnings Per Share (Tables) HTML 38K 34: R25 Organization and Basis of Presentation (Details) HTML 31K 35: R26 Acquisition of Eagle Alcohol (Details) HTML 44K 36: R27 Acquisition of Eagle Alcohol (Details) - Schedule HTML 25K of pro forma combined financial information assuming the acquisition occurred 37: R28 Acquisition of Eagle Alcohol (Details) - Schedule HTML 54K of preliminary purchase price allocation 38: R29 Segments (Details) HTML 18K 39: R30 Segments (Details) - Schedule of financial data HTML 86K for operating segments 40: R31 Segments (Details) - Schedule of assets by HTML 34K operating segments 41: R32 Inventories (Details) HTML 18K 42: R33 Inventories (Details) - Schedule of inventories HTML 28K 43: R34 Derivatives (Details) HTML 18K 44: R35 Derivatives (Details) - Schedule of derivatives HTML 26K not designated as hedging instruments 45: R36 Derivatives (Details) - Schedule of recognized HTML 26K gains (losses) for derivatives 46: R37 Debt (Details) HTML 18K 47: R38 Debt (Details) - Schedule of long-term borrowings HTML 25K 48: R39 Commitments and Contingencies (Details) HTML 39K 49: R40 Pension Plans (Details) HTML 45K 50: R41 Fair Value Measurements. (Details) HTML 18K 51: R42 Fair Value Measurements. (Details) - Schedule of HTML 72K recurring and nonrecurring fair value measurements 52: R43 Earnings Per Share (Details) HTML 23K 53: R44 Earnings Per Share (Details) - Schedule of compute HTML 62K basic and diluted earnings per share 56: XML IDEA XML File -- Filing Summary XML 101K 54: XML XBRL Instance -- f10q0322_altoingredi_htm XML 901K 55: EXCEL IDEA Workbook of Financial Reports XLSX 59K 6: EX-101.CAL XBRL Calculations -- alto-20220331_cal XML 97K 7: EX-101.DEF XBRL Definitions -- alto-20220331_def XML 490K 8: EX-101.LAB XBRL Labels -- alto-20220331_lab XML 971K 9: EX-101.PRE XBRL Presentations -- alto-20220331_pre XML 483K 5: EX-101.SCH XBRL Schema -- alto-20220331 XSD 121K 57: JSON XBRL Instance as JSON Data -- MetaLinks 304± 400K 58: ZIP XBRL Zipped Folder -- 0001213900-22-024981-xbrl Zip 145K
EXHIBIT 32.1
CERTIFICATIONS OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Alto Ingredients, Inc. (the “Company”) for the three months ended March 31, 2022 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 9, 2022 | By: | /s/ MICHAEL D. KANDRIS |
Michael D. Kandris | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) | ||
Dated: May 9, 2022 | By: | /s/ BRYON T. MCGREGOR |
Bryon T. McGregor | ||
Chief Financial Officer | ||
(Principal Financial Officer) |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 5/10/22 | |||
Filed on: | 5/9/22 | 8-K | ||
For Period end: | 3/31/22 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/13/22 Alto Ingredients, Inc. 424B3 12/12/22 1:190K EdgarAgents LLC/FA 11/29/22 Alto Ingredients, Inc. S-3 4:290K EdgarAgents LLC/FA 7/06/22 Alto Ingredients, Inc. S-8 7/06/22 5:266K EdgarAgents LLC/FA |